Advanced Solid Cancers Clinical Trials

19 clinical trials for Advanced Solid Cancers across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 — RECRUITING · PHASE1
• ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers — RECRUITING · PHASE1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor — RECRUITING · PHASE1
• Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients — RECRUITING · PHASE2
• Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers — RECRUITING · PHASE1
• A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors — RECRUITING · PHASE1
• Study of SC-102 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• First-in-human, Open-label, Multi-site, Phase I/IIa, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety and Preliminary Efficacy of BNT329 in Participants With Advanced Solid Tumors Known to Express CA19-9 — TERMINATED · PHASE2
• A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Exploratory Clinical Study on Memory NK Cell Therapy for Advanced Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy — COMPLETED · PHASE1
• An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers — COMPLETED · PHASE1
• Study of Personalized Neoantigen Specific TCR T cells in the Treatment of Advanced Solid Cancers — OTHER · PHASE1
• A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors — TERMINATED · PHASE1
• Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers — TERMINATED · PHASE1
• Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers — COMPLETED · PHASE1
• A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers — TERMINATED · PHASE1
• Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer — COMPLETED · PHASE1
• Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain — COMPLETED · PHASE2

Refine this search